ICU Medical (ICUI) Tops Q1 EPS by 13c, Reaffirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
ICU Medical, Inc. Announces First Quarter 2016 Results
May 10, 2016 4:05 PM EDTSAN CLEMENTE, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the first quarter ended March 31, 2016.
First Quarter 2016 Results
First quarter 2016 revenue was $89.9 million, compared to $81.5 million in the same period last year. GAAP net income for the first quarter of 2016 was $15.9 million, or $0.96 per diluted share, as compared to GAAP net income of $9.7 million, or $0.60 per diluted share, for... More
